We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week
Published in Bladder Cancer

Journal Scan / Research · September 22, 2021

Effects of Neoadjuvant Chemotherapy in Node-Positive Upper Tract Urothelial Carcinoma

Urologic Oncology: Seminars and Original Investigations


Additional Info

Urologic Oncology: Seminars and Original Investigations
Does neoadjuvant chemotherapy have therapeutic benefit for node-positive upper tract urothelial carcinoma? Results of a multi-center cohort study
Urol. Oncol 2021 Aug 25;[EPub Ahead of Print], K Shigeta, K Matsumoto, K Ogihara, T Murakami, T Anno, K Umeda, M Izawa, Y Baba, T Sanjo, K Shojo, N Tanaka, T Takeda, S Morita, T Kosaka, R Mizuno, Y Arita, H Akita, M Jinzaki, E Kikuchi, M Oya

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading